Thomas Martin

Thomas Martin is a leading expert in hematology-oncology at the University of California, San Francisco (UCSF) and serves as associate director of the myeloma program and director of unrelated donor transplantation programs at UCSF Medical Center. As clinical research director for hematologic malignancies at the UCSF Helen Diller Family Comprehensive Cancer Center, he focuses on developing treatments for myeloma and leukemia, with a special interest in bone marrow and umbilical cord blood transplants.

His recent publications highlight advancements in

• BCMA-targeting CAR-T therapy (Cilta-cel)
• Bispecific antibody treatments (Teclistamab)
• Geriatric frailty assessments in elderly myeloma patients
• Immune response dynamics post-immunotherapy

These works span collaborations with international research groups and emphasize real-world data and patient-reported outcomes.

Scientific awards include

• Cornell Tradition Fellow Award (1984)
• LANGE Book Award for Internal Medicine Scholarship (1989)
• Faculty Teaching Award, UCSF Hematology/Oncology Division (2003)

He has extensive experience in clinical research and education, having previously served as an assistant professor at MD Anderson Cancer Center.